Harpoon Therapeutics Funding & Investors
Harpoon Therapeutics is a clinical-stage immunotherapy company developing a novel class of T cell engagers that harness the power of the body’s immune system to treat patients suffering from cancer and other diseases. T cell engagers are engineered proteins that direct a patient’s own T cells to kil...Read more
harpoontx.comTotal Amount Raised: $230,000,000
Harpoon Therapeutics Funding Rounds
Series B
$45,000,000
Series B Investors
Arix BioscienceMPM CapitalTaiho VenturesUBS Asset ManagementNew Leaf Venture PartnersSeries A
$15,000,000
Series A Investors
MPM CapitalUBS Asset ManagementPost Ipo Equity
$100,000,000
Post Ipo Equity Investors
Ally Bridge GroupInvus GroupK2 HealthVenturesSoleus Capital ManagementLion Point CapitalCormorant Asset ManagementRA Capital ManagementSurveyor CapitalCommodore CapitalNew Leaf Venture PartnersSeries C
$70,000,000
Series C Investors
Ridgeback Capital ManagementArix Bioscienceoncology impact fundLilly Asia VenturesTaiho VenturesMPM CapitalUBS Asset ManagementNS InvestmentOrbiMed AdvisorsNew Leaf Venture Partners
Funding info provided by Diffbot.